Name | Number of supported studies | Average coverage | |
---|---|---|---|
astrocyte | 17 studies | 53% ± 22% | |
endothelial cell | 17 studies | 35% ± 10% | |
oligodendrocyte precursor cell | 12 studies | 57% ± 18% | |
fibroblast | 12 studies | 35% ± 9% | |
oligodendrocyte | 9 studies | 29% ± 15% | |
GABAergic neuron | 8 studies | 47% ± 18% | |
glutamatergic neuron | 8 studies | 42% ± 21% | |
adipocyte | 8 studies | 32% ± 7% | |
mesothelial cell | 8 studies | 43% ± 14% | |
smooth muscle cell | 8 studies | 30% ± 7% | |
pericyte | 6 studies | 20% ± 3% | |
interneuron | 5 studies | 46% ± 24% | |
endothelial cell of lymphatic vessel | 5 studies | 21% ± 6% | |
type II pneumocyte | 5 studies | 48% ± 9% | |
neuron | 4 studies | 44% ± 26% | |
Mueller cell | 4 studies | 56% ± 6% | |
retina horizontal cell | 4 studies | 44% ± 13% | |
granule cell | 3 studies | 29% ± 6% | |
microglial cell | 3 studies | 52% ± 14% | |
progenitor cell | 3 studies | 34% ± 6% | |
retinal rod cell | 3 studies | 20% ± 3% | |
endothelial cell of vascular tree | 3 studies | 33% ± 16% | |
ciliated cell | 3 studies | 24% ± 6% | |
club cell | 3 studies | 28% ± 11% | |
type I pneumocyte | 3 studies | 16% ± 1% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 100% | 2709.96 | 244 / 245 | 100% | 37.32 | 502 / 502 |
kidney | 100% | 1795.02 | 89 / 89 | 95% | 13.55 | 854 / 901 |
brain | 89% | 674.60 | 2347 / 2642 | 100% | 23.69 | 703 / 705 |
thymus | 100% | 1112.69 | 651 / 653 | 82% | 5.92 | 495 / 605 |
skin | 82% | 1710.04 | 1492 / 1809 | 95% | 19.22 | 450 / 472 |
adrenal gland | 100% | 1596.50 | 258 / 258 | 76% | 9.35 | 175 / 230 |
pancreas | 88% | 520.59 | 290 / 328 | 85% | 7.66 | 151 / 178 |
lung | 100% | 1315.87 | 577 / 578 | 65% | 5.35 | 753 / 1155 |
breast | 100% | 1403.46 | 459 / 459 | 60% | 3.87 | 666 / 1118 |
ovary | 100% | 1857.87 | 180 / 180 | 59% | 3.89 | 255 / 430 |
bladder | 100% | 2206.71 | 21 / 21 | 53% | 4.19 | 267 / 504 |
uterus | 99% | 1166.92 | 169 / 170 | 41% | 4.89 | 186 / 459 |
esophagus | 83% | 832.47 | 1197 / 1445 | 37% | 2.51 | 68 / 183 |
stomach | 87% | 632.75 | 313 / 359 | 33% | 2.08 | 93 / 286 |
intestine | 87% | 1101.53 | 839 / 966 | 30% | 1.93 | 157 / 527 |
blood vessel | 100% | 2289.25 | 1335 / 1335 | 0% | 0 | 0 / 0 |
adipose | 100% | 1312.85 | 1202 / 1204 | 0% | 0 | 0 / 0 |
spleen | 82% | 369.80 | 198 / 241 | 0% | 0 | 0 / 0 |
heart | 81% | 506.43 | 695 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 60% | 3.49 | 48 / 80 |
tonsil | 0% | 0 | 0 / 0 | 51% | 2.82 | 23 / 45 |
liver | 15% | 54.32 | 33 / 226 | 27% | 1.78 | 109 / 406 |
muscle | 13% | 47.09 | 103 / 803 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 3% | 0.15 | 1 / 29 |
peripheral blood | 1% | 2.51 | 6 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0030148 | Biological process | sphingolipid biosynthetic process |
GO_0018105 | Biological process | peptidyl-serine phosphorylation |
GO_1904628 | Biological process | cellular response to phorbol 13-acetate 12-myristate |
GO_0001525 | Biological process | angiogenesis |
GO_0060298 | Biological process | positive regulation of sarcomere organization |
GO_0006954 | Biological process | inflammatory response |
GO_0007200 | Biological process | phospholipase C-activating G protein-coupled receptor signaling pathway |
GO_0071447 | Biological process | cellular response to hydroperoxide |
GO_0010976 | Biological process | positive regulation of neuron projection development |
GO_0043536 | Biological process | positive regulation of blood vessel endothelial cell migration |
GO_0045766 | Biological process | positive regulation of angiogenesis |
GO_0045087 | Biological process | innate immune response |
GO_2001044 | Biological process | regulation of integrin-mediated signaling pathway |
GO_0050829 | Biological process | defense response to Gram-negative bacterium |
GO_0007165 | Biological process | signal transduction |
GO_0010595 | Biological process | positive regulation of endothelial cell migration |
GO_0033138 | Biological process | positive regulation of peptidyl-serine phosphorylation |
GO_0010628 | Biological process | positive regulation of gene expression |
GO_0018107 | Biological process | peptidyl-threonine phosphorylation |
GO_0042307 | Biological process | positive regulation of protein import into nucleus |
GO_0045806 | Biological process | negative regulation of endocytosis |
GO_0046827 | Biological process | positive regulation of protein export from nucleus |
GO_0090277 | Biological process | positive regulation of peptide hormone secretion |
GO_0045669 | Biological process | positive regulation of osteoblast differentiation |
GO_0048193 | Biological process | Golgi vesicle transport |
GO_0051092 | Biological process | positive regulation of NF-kappaB transcription factor activity |
GO_0071874 | Biological process | cellular response to norepinephrine stimulus |
GO_1900227 | Biological process | positive regulation of NLRP3 inflammasome complex assembly |
GO_0007030 | Biological process | Golgi organization |
GO_0007229 | Biological process | integrin-mediated signaling pathway |
GO_0035556 | Biological process | intracellular signal transduction |
GO_0034599 | Biological process | cellular response to oxidative stress |
GO_1990859 | Biological process | cellular response to endothelin |
GO_0001938 | Biological process | positive regulation of endothelial cell proliferation |
GO_0043123 | Biological process | positive regulation of canonical NF-kappaB signal transduction |
GO_0030154 | Biological process | cell differentiation |
GO_0010508 | Biological process | positive regulation of autophagy |
GO_2001028 | Biological process | positive regulation of endothelial cell chemotaxis |
GO_0034198 | Biological process | cellular response to amino acid starvation |
GO_0006915 | Biological process | apoptotic process |
GO_0048010 | Biological process | vascular endothelial growth factor receptor signaling pathway |
GO_0051279 | Biological process | regulation of release of sequestered calcium ion into cytosol |
GO_0051897 | Biological process | positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction |
GO_0045793 | Biological process | positive regulation of cell size |
GO_0046777 | Biological process | protein autophosphorylation |
GO_0010837 | Biological process | regulation of keratinocyte proliferation |
GO_0035924 | Biological process | cellular response to vascular endothelial growth factor stimulus |
GO_0007399 | Biological process | nervous system development |
GO_0014723 | Biological process | regulation of skeletal muscle contraction by modulation of calcium ion sensitivity of myofibril |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_1904385 | Biological process | cellular response to angiotensin |
GO_0005886 | Cellular component | plasma membrane |
GO_0048471 | Cellular component | perinuclear region of cytoplasm |
GO_0030018 | Cellular component | Z disc |
GO_0000421 | Cellular component | autophagosome membrane |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0005911 | Cellular component | cell-cell junction |
GO_0005802 | Cellular component | trans-Golgi network |
GO_0005829 | Cellular component | cytosol |
GO_0005938 | Cellular component | cell cortex |
GO_0005634 | Cellular component | nucleus |
GO_0005080 | Molecular function | protein kinase C binding |
GO_0141038 | Molecular function | phosphatidylinositol 3-kinase activator activity |
GO_0106310 | Molecular function | protein serine kinase activity |
GO_0031072 | Molecular function | heat shock protein binding |
GO_0004674 | Molecular function | protein serine/threonine kinase activity |
GO_0042802 | Molecular function | identical protein binding |
GO_0046872 | Molecular function | metal ion binding |
GO_0005524 | Molecular function | ATP binding |
GO_0016301 | Molecular function | kinase activity |
GO_0004697 | Molecular function | diacylglycerol-dependent serine/threonine kinase activity |
GO_0005515 | Molecular function | protein binding |
Gene name | PRKD1 |
Protein name | Serine/threonine-protein kinase (EC 2.7.11.13) Serine/threonine-protein kinase D1 (EC 2.7.11.13) (Protein kinase C mu type) (Protein kinase D) (nPKC-D1) (nPKC-mu) Protein kinase D1 |
Synonyms | PKD PRKCM PKD1 |
Description | FUNCTION: Serine/threonine-protein kinase that converts transient diacylglycerol (DAG) signals into prolonged physiological effects downstream of PKC, and is involved in the regulation of MAPK8/JNK1 and Ras signaling, Golgi membrane integrity and trafficking, cell survival through NF-kappa-B activation, cell migration, cell differentiation by mediating HDAC7 nuclear export, cell proliferation via MAPK1/3 (ERK1/2) signaling, and plays a role in cardiac hypertrophy, VEGFA-induced angiogenesis, genotoxic-induced apoptosis and flagellin-stimulated inflammatory response . Phosphorylates the epidermal growth factor receptor (EGFR) on dual threonine residues, which leads to the suppression of epidermal growth factor (EGF)-induced MAPK8/JNK1 activation and subsequent JUN phosphorylation . Phosphorylates RIN1, inducing RIN1 binding to 14-3-3 proteins YWHAB, YWHAE and YWHAZ and increased competition with RAF1 for binding to GTP-bound form of Ras proteins (NRAS, HRAS and KRAS). Acts downstream of the heterotrimeric G-protein beta/gamma-subunit complex to maintain the structural integrity of the Golgi membranes, and is required for protein transport along the secretory pathway. In the trans-Golgi network (TGN), regulates the fission of transport vesicles that are on their way to the plasma membrane. May act by activating the lipid kinase phosphatidylinositol 4-kinase beta (PI4KB) at the TGN for the local synthesis of phosphorylated inositol lipids, which induces a sequential production of DAG, phosphatidic acid (PA) and lyso-PA (LPA) that are necessary for membrane fission and generation of specific transport carriers to the cell surface. Under oxidative stress, is phosphorylated at Tyr-463 via SRC-ABL1 and contributes to cell survival by activating IKK complex and subsequent nuclear translocation and activation of NFKB1 . Involved in cell migration by regulating integrin alpha-5/beta-3 recycling and promoting its recruitment in newly forming focal adhesion. In osteoblast differentiation, mediates the bone morphogenetic protein 2 (BMP2)-induced nuclear export of HDAC7, which results in the inhibition of HDAC7 transcriptional repression of RUNX2 . In neurons, plays an important role in neuronal polarity by regulating the biogenesis of TGN-derived dendritic vesicles, and is involved in the maintenance of dendritic arborization and Golgi structure in hippocampal cells. May potentiate mitogenesis induced by the neuropeptide bombesin or vasopressin by mediating an increase in the duration of MAPK1/3 (ERK1/2) signaling, which leads to accumulation of immediate-early gene products including FOS that stimulate cell cycle progression. Plays an important role in the proliferative response induced by low calcium in keratinocytes, through sustained activation of MAPK1/3 (ERK1/2) pathway. Downstream of novel PKC signaling, plays a role in cardiac hypertrophy by phosphorylating HDAC5, which in turn triggers XPO1/CRM1-dependent nuclear export of HDAC5, MEF2A transcriptional activation and induction of downstream target genes that promote myocyte hypertrophy and pathological cardiac remodeling . Mediates cardiac troponin I (TNNI3) phosphorylation at the PKA sites, which results in reduced myofilament calcium sensitivity, and accelerated crossbridge cycling kinetics. The PRKD1-HDAC5 pathway is also involved in angiogenesis by mediating VEGFA-induced specific subset of gene expression, cell migration, and tube formation . In response to VEGFA, is necessary and required for HDAC7 phosphorylation which induces HDAC7 nuclear export and endothelial cell proliferation and migration. During apoptosis induced by cytarabine and other genotoxic agents, PRKD1 is cleaved by caspase-3 at Asp-378, resulting in activation of its kinase function and increased sensitivity of cells to the cytotoxic effects of genotoxic agents . In epithelial cells, is required for transducing flagellin-stimulated inflammatory responses by binding and phosphorylating TLR5, which contributes to MAPK14/p38 activation and production of inflammatory cytokines . Acts as an activator of NLRP3 inflammasome assembly by mediating phosphorylation of NLRP3 (By similarity). May play a role in inflammatory response by mediating activation of NF-kappa-B. May be involved in pain transmission by directly modulating TRPV1 receptor . Plays a role in activated KRAS-mediated stabilization of ZNF304 in colorectal cancer (CRC) cells . Regulates nuclear translocation of transcription factor TFEB in macrophages upon live S.enterica infection (By similarity). . |
Accessions | Q1KKQ2 H0YHL5 ENST00000549503.1 A0A494C0Q1 Q15139 ENST00000651571.1 ENST00000490795.1 ENST00000331968.11 F8WBA3 A0A494C196 F8VZ98 ENST00000415220.6 ENST00000546371.1 ENST00000651616.1 H0YHS9 |